-
Higher BMI as Teenagers Raises Risk of MS for Men, Study Finds
NewsYoung men, ages 16 to 20, with a higher the body mass index (BMI) are at greater their risk ... Read more -
Tecfidera Safe and Effective in Hispanic/Latino MS Patients, Real-world Data Show
NewsTecfidera (dimethyl fumarate) is as safe and effective in Hispanic/Latino multiple sclerosis (MS) patients as it is in their non-Hispanic and ... Read more -
How to Feed Your Soul and Find Positivity Amid MS
Columns, Silver Linings - a Column by Jennifer PowellOur thoughts influence our being. The stories we tell ourselves frame our reality. They affect the decisions we make, ... Read more -
Osmotica Amends NDA for Arbaclofen ER to Treat MS Spasticity
NewsOsmotica Pharmaceuticals has submitted an amended new drug application (NDA) to the U.S. Food and Drug Administration (FDA) requesting ... Read more -
PROTXX, University of Alberta Collaborate to Develop Remote Healthcare Platform for MS Patients
NewsThe University of Alberta and PROTXX are collaborating to develop wearable sensors for people with multiple sclerosis (MS) and advance a ... Read more -
Anxiety and Depression Linked to RRMS Relapse Risk, Study Finds
NewsComorbidities such as anxiety and depression are associated with a significantly increased risk of relapse in people with ... Read more -
Exposure to DMTs Does Not Increase Risk of Severe COVID-19 in MS Patients, Study Finds
NewsExposure to disease-modifying therapies does not increase multiple sclerosis (MS) patients’ risk of developing a severe form of COVID-19, according ... Read more -
3 Things to Do If You’re Freaked Out by Blood Tests
Columns, DISabled to ENabled – a Column by Jessie AceWhen I was newly diagnosed seven years ago, one of the hardest things to deal with was the idea ... Read more -
Study of Temelimab in MS Progression Without Relapse Enrolls 1st Patient
NewsGeNeuro announced that a first multiple sclerosis (MS) patient has enrolled in its Phase 2 trial assessing the safety and effectiveness of ... Read more -
Boosting Cellular Energy at Sites of Myelin Loss May Stop MS Progression
NewsLoss of myelin in nerve cell fibers — the hallmark of multiple sclerosis (MS) — leads to a shortage ... Read more -
MS News That Caught My Eye Last Week: Mayzent, Hookworm Therapy, Walking and Falling, ADS-5102
Columns, The MS Wire - A Column by Ed TobiasNICE Does Not Favor Adding Mayzent to NHS England for Active SPMS Currently, the only disease-modifying therapy approved ... Read more -
Tecfidera Safe and Effective Over Years of Use, RRMS Study Finds
NewsTecfidera (dimethyl fumarate) is safe and effective as a long-term treatment for relapsing-remitting multiple sclerosis (RRMS), a ... Read more
What can we help you find today?
